Copaxone demonstrates remyelination & neuroprotective effect
Copaxone demonstrates remyelination & neuroprotective effect
Teva Pharmaceutical Industries Ltd. today announced preclinical data demonstrating reparative and neuroprotective effects of treatment with Copaxone(R) (glatiramer acetate injection) in experimental autoimmune encephalomyelitis (EAE) models. In the study, researchers compared mice treated with Copaxone(R) versus non-treated mice in relapsing-remitting and chronic multiple sclerosis (MS) disease models. Researchers observed both remyelination indicative of repair and a drastic reduction of demyelination and axonal loss in mice treated with Copaxone(R).... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1767
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2029 Views
-
Last post by NHE
-
- 0 Replies
- 2221 Views
-
Last post by NHE
-
- 0 Replies
- 1357 Views
-
Last post by NHE
-
- 0 Replies
- 1248 Views
-
Last post by DIM
-
- 0 Replies
- 1054 Views
-
Last post by frodo
-
- 0 Replies
- 1136 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1100 Views
-
Last post by frodo
-
- 0 Replies
- 1261 Views
-
Last post by NHE
-
- 1 Replies
- 2910 Views
-
Last post by Tif